TA Head New Products, Medical Affairs (m/f/x)

at  Daiichi Sankyo Europe

The Head TA New Products (Medical Affairs) is responsible to proactively screen and evaluate new potential assets to be in-licensed to DSE SBD from a medical perspective, together with a x-functional team at DSE (Market Access and Commercial) and other global partners (especially BD, global medical affairs, global marketing, global strategy)

EDUCATION & PROFESSIONAL EXPERIENCE:

• MD preferred, University degree in natural sciences (medicine, pharmacy, chemistry, biotechnology, biology or equivalent) followed by 15+ years of experience in relevant roles/positions
• Deep scientific and medical expertise in a broad field of disease areas, focus on cardiovascular and immunological diseases is a plus
• Previous experience in R&D throughout all phases and experience in planning a product life cycle management program
• Experience in Marketing Authorization Applications
• Experience on active participation in Due Diligence activities and processes is a plus
• Experience ideally in evaluating new candidates for pipeline in cardiovascular-metabolic area in defining target product profiles and evaluating risk benefit profiles in relation to current and anticipated future landscape.
• Demonstrate creativity and practice change management in order to guarantee a continuous improvement
• Proven leadership skills in a matrix environment
• Show empathy, respect and fairness
• Live a culture of cooperation and team-work and take action to prevent and solve conflicts
• Ability to work independently and as part of a team
• Work proactively and encouraging others, show assertiveness and strong resilience
• Strong communication, negotiation and presentation skills
• Effective planning und review of projects
• Analytical and systematic thinking, problem solving and ability to drive medical decisions

• Matrix lead of a x-functional team at Daiichi Sankyo Europe, driving in-licensing activities
• Lead of a small medical team with 1 to 2 direct reports
• Planning, leading, and executing the multi-discipline, multi-location, product verification aspect of new candidates
• Lead the search, triage and evaluation of in-licensing opportunities from biotech and peer-pharma, including early research projects, new modality platforms, pre-clinical and clinical stage assets and Life Cycle Management (LCM) opportunities
• Active participation and contribution into highest global R&D board, i.e. Global Portfolio and Asset Decision Committee (G-PAD)
• Establish and lead Due Diligence teams at DSE and process to drive the detailed scientific evaluation of potential assets to support recommendations at governance
• Prepare materials for senior management briefings of recommended opportunities
• Ensure effective communication during BD process with key internal partners and cross-functional teams
• Building and maintaining a broad network of internal and external partners
• Leveraging relevant database and analytics tools to curate technology and disease (target) biology maps in support of opportunity identification and prioritization, and anticipation of new entry points
• Support the evaluation of new database/analytics to improve upon curation of insights
• Conduct primary and secondary research in support of due diligence and/or strategic projects which may include, but is not limited to: KEE interfacing, medical/scientific congress attendance, review of scientific literature, and analyzing/tracking key competitors
• Producing a landscape assessment to give an idea of the current, and future, competitive dynamics of the disease space
• Continuously analyzing data to provide a medical judgment of the new candidates on the success of an approval
• Responsible for the entire medical assessment of the new candidate including the target product profile establishment and the review of the competitive landscape
• Provide recommendations for product improvements and enhancements